Revelation Biosciences, Inc. Common Stock (REVB) is a publicly traded Healthcare sector company. As of May 21, 2026, REVB trades at $1.07 with a market cap of $4.06M and a P/E ratio of -0.04. REVB moved +0.00% today. Year to date, REVB is -67.52%; over the trailing twelve months it is -96.38%. Its 52-week range spans $0.88 to $241.92. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces REVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Revelation Biosciences, Inc. Common Stock (REVB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. REVB moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $4.06M |
| P/E Ratio | -0.04 |
| EPS | $-23.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $241.92 |
| 52-Week Low | $0.88 |
| Volume | 30.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.91M |
| Gross Margin | 0.00% |
1 analysts cover REVB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.